Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples.
about
Surface-mediated control of blood coagulation: the role of binding site densities and platelet depositionBiology of tissue factor pathway inhibitor.Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitorMurine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitorTumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension.Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor.Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flowTissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.Expression of tissue factor pathway inhibitor by endothelial cells and plateletsHow it all starts: Initiation of the clotting cascade.Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition.Targeting TFPI for hemophilia treatment.Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.Tissue factor pathway inhibitor: structure-function.Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.Computational Study of Thrombus Formation and Clotting Factor Effects under Venous Flow Conditions.Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells.Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?A Mathematical Model of Venous Thrombosis Initiation.Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.Flow-simulated thrombin generation profiles as a predictor of thrombotic risk among pre-menopausal women.
P2860
Q33336176-8EFDB358-268B-4E64-91E7-77D2A9B79BBDQ33585249-F66A6890-B4DF-491F-895F-FB8962E4FE56Q33648222-8C79F2CA-620E-400D-A3F1-09ED2EA0EB20Q33679198-4324E1EF-B059-49C3-9AD8-3BADEC8E0D67Q33901970-6D12492B-BFF4-43A5-A96A-48CFE3256444Q33921037-10469FA1-4708-4503-AED8-87939BCF54C8Q34026306-5E84A886-5BA0-4BC7-B078-5485AD8EC25EQ34056269-9321C102-1475-4F55-9054-F1F90C3E5691Q35589734-D9B141E9-AB7E-4DE4-83FA-2D651E6D5D5AQ35611991-DF4B5FB0-0410-4347-B16F-E135E24436C8Q35750357-8BED9485-5044-41DA-B484-B3796E0DB70DQ35963106-1A9AACFF-11AC-4E6A-9CD8-1D2B96D742AFQ36269547-0AD223E7-78D4-400A-931A-AE93581ACDC0Q36402078-00BB1EFD-5F5A-40B8-B63E-F16D6FC05CBCQ36403196-EE372CCA-3D48-4301-BAFC-FCAD3ADA7B13Q36547412-9CA96828-CA9E-46AE-8545-1504A76AB6A6Q36691629-A50ED866-8651-4572-A52E-79F8ADFB3C51Q36783613-A0C32F57-3EAC-4F9E-B6E7-99478E98D7B4Q36823197-9F50A226-C5B6-417B-88E8-87B22EEEA709Q37108074-797C83B7-7335-4755-9C95-4232B6C910C8Q37276726-CBFDFFB3-C1D2-44A5-8955-6C6C0BAAEBFCQ37357497-1455FE3A-F34F-4636-BD1E-DD91AFFF3B90Q37418452-5A9CF0C8-4F96-4B2B-AFDB-58C1F3619A74Q37971520-D6F1117E-442D-44E1-BCBC-BDCC0BB9995CQ39683706-4EC5E100-205D-4207-AEDB-72A3CA36A9FFQ39817818-AB756C7A-058D-455D-B70E-4CCB90C1B945Q41936652-49CF94C2-1236-4F8D-8F94-8F9C208C35C8Q41982133-728E74AB-041E-4BB2-A71D-48DD61C994DCQ42158171-CF1E77E2-6652-44A9-A739-7BF7AF0BDA4AQ42700253-1CBDFF0B-817A-4547-AEDA-100414E914D2Q42723158-2E1FAE73-5339-4D0F-9296-1C8086E1F8FBQ46599341-D0E97542-B35C-4A41-AE0B-C5056E39DD9CQ55447752-8A440D20-1AF3-445A-A29A-BC6CD97E4096Q55547491-52B13255-B3A3-4174-A65D-D305715D9EAF
P2860
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Plasma antigen levels of the l ...... inhibitor in patient samples.
@en
type
label
Plasma antigen levels of the l ...... inhibitor in patient samples.
@en
prefLabel
Plasma antigen levels of the l ...... inhibitor in patient samples.
@en
P2093
P1433
P1476
Plasma antigen levels of the l ...... inhibitor in patient samples.
@en
P2093
P304
P407
P577
1991-07-01T00:00:00Z